These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32928961)

  • 21. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
    Fernando AN; Furtado PB; Clark SJ; Gilbert HE; Day AJ; Sim RB; Perkins SJ
    J Mol Biol; 2007 Apr; 368(2):564-81. PubMed ID: 17362990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
    Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
    J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
    Okemefuna AI; Nan R; Miller A; Gor J; Perkins SJ
    J Biol Chem; 2010 Jan; 285(2):1053-65. PubMed ID: 19850925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin.
    Khan S; Nan R; Gor J; Mulloy B; Perkins SJ
    Biochem J; 2012 Jun; 444(3):417-28. PubMed ID: 22471560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation.
    Okemefuna AI; Li K; Nan R; Ormsby RJ; Sadlon T; Gordon DL; Perkins SJ
    J Mol Biol; 2009 Aug; 391(1):119-35. PubMed ID: 19505474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patients.
    DeCordova S; Abdelgany A; Murugaiah V; Pathan AA; Nayak A; Walker T; Shastri A; Alrokayan SH; Khan HA; Singh SK; De Pennington N; Sim RB; Kishore U
    Immunobiology; 2019 Sep; 224(5):625-631. PubMed ID: 31519376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.
    Hui GK; Gardener AD; Begum H; Eldrid C; Thalassinos K; Gor J; Perkins SJ
    J Biol Chem; 2019 Jul; 294(28):10789-10806. PubMed ID: 31088911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM; Rakstang JK; Young KA; Hinshelwood J; Aslam M; Robertson A; Gipson MG; Sarrias MR; Moore WT; Meagher M; Karp D; Lambris JD; Perkins SJ; Holers VM
    Biochemistry; 2001 May; 40(20):5931-41. PubMed ID: 11352728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions.
    Gilbert HE; Asokan R; Holers VM; Perkins SJ
    J Mol Biol; 2006 Oct; 362(5):1132-47. PubMed ID: 16950392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.
    Sharma AK; Pangburn MK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10996-1001. PubMed ID: 8855297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering.
    Perkins SJ; Smith KF; Sim RB
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):101-8. PubMed ID: 8216202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
    Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
    Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC
    Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment.
    Medjeral-Thomas NR; Moffitt H; Lomax-Browne HJ; Constantinou N; Cairns T; Cook HT; Pickering MC
    Kidney Int Rep; 2019 Oct; 4(10):1387-1400. PubMed ID: 31701048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces.
    Chen Q; Manzke M; Hartmann A; Büttner M; Amann K; Pauly D; Wiesener M; Skerka C; Zipfel PF
    J Am Soc Nephrol; 2016 May; 27(5):1413-25. PubMed ID: 26432903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
    Nan R; Gor J; Perkins SJ
    J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system.
    Perkins SJ; Smith KF; Kilpatrick JM; Volanakis JE; Sim RB
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):87-99. PubMed ID: 8216242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.
    Frangou E; Varnavidou-Nicolaidou A; Petousis P; Soloukides A; Theophanous E; Savva I; Michael N; Toumasi E; Georgiou D; Stylianou G; Mean R; Anastasiadou N; Athanasiou Y; Zavros M; Kyriacou K; Deltas C; Hadjianastassiou V
    Nephrol Dial Transplant; 2019 Oct; 34(10):1780-1788. PubMed ID: 30844074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.